Utah Medical Products UTMD Deferred taxes
Deferred taxes at other companies
Other financials
Where this comes from
Reported directly by Utah Medical Products in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxExpenseBenefit.
The official record: Utah Medical Products’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Utah Medical Products's deferred taxes.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Utah Medical Products's deferred taxes?
- Utah Medical Products (UTMD) reported deferred taxes of -$157K in Q1 2026.
- How has Utah Medical Products's deferred taxes changed year-over-year?
- Utah Medical Products's deferred taxes increased by 24.9% year-over-year, from -$209K to -$157K.
- What is the long-term trend for Utah Medical Products's deferred taxes?
- Over 2 years (2022 to 2025), Utah Medical Products's deferred taxes has grown at a 25.2% compound annual growth rate (CAGR), from -$409K to -$641K.
- What does deferred taxes mean?
- The aggregate net change in deferred tax assets and liabilities arising from temporary differences between the financial statement and tax bases of assets and liabilities. This metric indicates the non-cash tax impact of accounting adjustments that will reverse in future periods. It is a key indicator of the company's future tax cash flow requirements.